Related Experiment Video
Updated: Oct 17, 2025
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis
Miaomiao Ye1, Yibin Lin1, Shuya Pan1
1Center of Uterine Cancer Diagnosis & Therapy Research of Zhejiang Province, Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Abstract:
Ovarian cancer ranks as the fifth most common cause of cancer-related death in females. The molecular mechanisms of ovarian carcinogenesis need to be explored in order to identify effective clinical therapies for ovarian cancer. Recently, multi-omics approaches have been applied to determine the mechanisms of ovarian oncogenesis at genomics (DNA), transcriptomics (RNA), proteomics (proteins), and metabolomics (metabolites) levels. Multi-omics approaches can identify some diagnostic and prognostic biomarkers and therapeutic targets for ovarian cancer, and these molecular signatures are beneficial for clarifying the development and progression of ovarian cancer. Moreover, the discovery of molecular signatures and targeted therapy strategies could noticeably improve the prognosis of ovarian cancer patients.
Insights
Exploring ovarian cancer
Area of Science:
- Oncology
- Genetics
- Biochemistry
Background:
- Ovarian cancer is a leading cause of cancer death in women.
- Understanding the molecular basis of ovarian cancer is crucial for developing effective treatments.
Purpose of the Study:
- To explore the molecular mechanisms of ovarian carcinogenesis.
- To identify diagnostic and prognostic biomarkers and therapeutic targets for ovarian cancer.
Main Methods:
- Utilizing multi-omics approaches.
- Analyzing genomics (DNA), transcriptomics (RNA), proteomics (proteins), and metabolomics (metabolites).
Main Results:
- Multi-omics approaches reveal molecular signatures of ovarian cancer.
- Identified potential biomarkers and therapeutic targets.
Conclusions:
- Molecular signatures aid in understanding ovarian cancer development and progression.
- Targeted therapies and biomarker discovery can improve patient prognosis.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
12:42Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
